The 5 most recent market catalysts affecting $OPK, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 13, 2026
Corporate Catalyst
Neutral
Impact 65
OPKO Health Issues Additional $125M Of Senior Secured Notes To KKR's HealthCare Royalty For Non-Dilutive Funding
OPKO Health has successfully raised an additional $125 million through a non-dilutive financing arrangement with KKR's HealthCare Royalty. This deal leverages OPKO's future royalty…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 65
12 Health Care Stocks Moving In Tuesday's Intraday Session
The filing details the intraday performance of 12 healthcare stocks, with six experiencing significant gains and six experiencing substantial losses. The primary catalyst for sever…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 75
Opko Health shares are trading higher after the company reported better-than-expected Q2 sales results.
This headline represents a significant corporate catalyst for Opko Health. Better-than-expected sales directly impact a company's revenue and profitability outlook, often leading t…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 75
OPKO Health Raises FY2026 Sales Guidance from $530.000M-$560.000M to $560.000M-$585.000M vs $534.899M Est
OPKO Health (OPK) has announced a significant upward revision to its fiscal year 2026 sales guidance. The new range of $560 million-$585 million is substantially higher than both t…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 75
Opko Health shares are trading higher after the company reported better-tan-expected Q2 sales results.
This headline represents a significant corporate catalyst for Opko Health. Better-than-expected sales directly impact revenue and profitability projections, often leading to upward…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.